Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 16 results.
User Information
Export Records
  1. 1.   JS-K, a Glutathione S-Transferase-Activated Nitric Oxide Donor With Antineoplastic Activity in Malignant Gliomas
  2. Weyerbrock, A.; Osterberg, N.; Psarras, N.; Baumer, B.; Kogias, E.; Werres, A.; Bette, S.; Saavedra, J. E.; Keefer, L. K.; Papazoglou, A.
  3. Neurosurgery. 2012, Feb; 70(2): 497-510.
  1. 2.   Synthesis and Antitumor Molecular Mechanism of Agents Based on Amino 2-(3 ',4 ',5 '-Trimethoxybenzoyl)benzo[b]furan: Inhibition of Tubulin and Induction of Apoptosis
  2. Romagnoli, R.; Baraldi, P. G.; Lopez-Cara, C.; Cruz-Lopez, O.; Carrion, M. D.; Salvador, M. K.; Bermejo, J.; Estevez, S.; Estevez, F.; Balzarini, J.; Brancale, A.; Ricci, A.; Chen, L. C.; Kim, J. G.; Hamel, E.
  3. Chemmedchem. 2011, Oct; 6(10): 1841-1853.
  1. 3.   IL-3-mediated TNF production is necessary for mast cell development
  2. Wright, H. V.; Bailey, D.; Kashyap, M.; Kepley, C. L.; Drutskaya, M. S.; Nedospasov, S. A.; Ryan, J. J.
  3. Journal of Immunology. 2006, FEB 15; 176(4): 2114-2121.
  1. 4.   HIV gp41-induced apoptosis is mediated by caspase-3-dependent mitochondrial depolarization, which is inhibited by HIV protease inhibitor nelfinavir
  2. Garg, H.; Blumenthal, R.
  3. Journal of Leukocyte Biology. 2006, Feb; 79(2): 351-362.
  1. 5.   Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy
  2. Sayers, T. J.; Murphy, W. J.
  3. Cancer Immunology Immunotherapy. 2006, JAN; 55(1): 76-84.
  1. 6.   Induction of apoptosis by flavopiridol in human neuroblastoma cells is enhanced under hypoxia and associated with N-myc proto-oncogene down-regulation
  2. Puppo, M.; Pastorino, S.; Melillo, G.; Pezzolo, A.; Varesio, L.; Bosco, M. C.
  3. Clinical Cancer Research. 2004, DEC 15; 10(24): 8704-8719.
  1. 7.   JS-K, a novel nitric oxide (NO) generator, induces cytochrome c release and caspase activation in HL-60 myeloid leukemia cells
  2. Shami, P. J.; Udupi, V.; Yu, M.; Malaviya, S.; Saavedra, J. E.; Keefer, L. K.
  3. Blood. 2004, NOV 16; 104(11, Part 1, Abstract 3415): 931A-931A.
  1. 8.   Caspase-mediated apoptosis and caspase-independent cell death induced by irofulven in prostate cancer cells
  2. Liang, H. Y.; Salinas, R. A.; Leal, B. Z.; Kosakowska-Cholody, T.; Michejda, C. J.; Waters, S. J.; Herman, T. S.; Woynarowski, J. M.; Woynarowska, B. A.
  3. Molecular Cancer Therapeutics. 2004, NOV; 3(11): 1385-1396.
  1. 9.   Components of the cell death machine and drug sensitivity of the National Cancer Institute cell line panel
  2. Svingen, P. A.; Loegering, D.; Rodriquez, J.; Meng, X. W.; Mesner, P. W.; Holbeck, S.; Monks, A.; Krajewski, S.; Scudiero, D. A.; Sausville, E. A.; Reed, J. C.; Lazebnik, Y. A.; Kaufmann, S. H.
  3. Clinical Cancer Research. 2004, OCT 15; 10(20): 6807-6820.
  1. 10.   Getting back on track, or what to do when apoptosis is de-railed - Recoupling oncogenes to the apoptotic machinery
  2. Fearnhead, H. O.
  3. Cancer Biology & Therapy. 2004 3(1): 21-28.
  1. 11.   Apo cytochrome c inhibits caspases by preventing apoptosome formation
  2. Martin, A. G.; Nguyen, J.; Wells, J. A.; Fearnhead, H. O.
  3. Biochemical and Biophysical Research Communications. 2004 319(3): 944-950.
  1. 12.   Discordant regulation of granzyme H and granzyme B expression in human lymphocytes
  2. Sedelies, K. A.; Sayers, T. J.; Edwards, K. M.; Chen, W. S.; Pellicci, D. G.; Godfrey, D. I.; Trapani, J. A.
  3. Journal of Biological Chemistry. 2004 279(25): 26581-26587.
  1. 13.   A high-throughput screen for identification of molecular mimics of Smac/DIABLO utilizing a fluorescence polarization assay
  2. Glover, C. J.; Hite, K.; DeLosh, R.; Scudiero, D. A.; Fivash, M. J.; Smith, L. R.; Fisher, R. J.; Wu, J. W.; Shi, Y. G.; Kipp, R. A.; McLendon, G. L.; Sausville, E. A.; Shoemaker, R. H.
  3. Analytical Biochemistry. 2003 320(2): 157-169.
  1. 14.   Expression of Bcl-2 family member bid in normal and malignant tissues
  2. Krajewska, M.; Zapata, J. M.; Meinhold-Heerlein, I.; Hedayat, H.; Monks, A.; Bettendorf, H.; Shabaik, A.; Bubendorf, L.; Kallioniemi, O. P.; Kim, H.; Reifenberger, G.; Reed, J. C.; Krajewski, S.
  3. Neoplasia. 2002 4(2): 129-140.
  1. 15.   Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family
  2. Richter, B. W. M.; Mir, S. S.; Eiben, L. J.; Lewis, J.; Reffey, S. B.; Frattini, A.; Tian, L.; Frank, S.; Youle, R. J.; Nelson, D. L.; Notarangelo, L. D.; Vezzoni, P.; Fearnhead, H. O.; Duckett, C. S.
  3. Molecular and Cellular Biology. 2001 21(13): 4292-4301.
  1. 16.   Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: Evidence for cytotoxic mechanisms different from inhibition of protein synthesis
  2. Iordanov, M. S.; Ryabinina, O. P.; Wong, J.; Dinh, T. H.; Newton, D. L.; Rybak, S. M.; Magun, B. E.
  3. Cancer Research. 2000 60(7): 1983-1994.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel